TransMedics, Inc. Receives FDA Pre-Market Approval (PMA) for its OCS(TM) Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation

ANDOVER, Mass., April 12, 2018 -- (Healthcare Sales & Marketing Network) -- TransMedics, Inc., a medical technology company that is transforming the important therapy of solid organ transplantation for patients with end-stage lung, heart and liver failure... Devices, Surgery, FDA TransMedics, Organ Care System, lung transplant, organ transplant
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news